2. Patients with MM, NHL, HL and CLL with an indication for allogeneic transplantation as follows:
1. MM; patients relapsing after autologous transplant or with high-risk cytogenetic abnormalities
2. Aggressive lymphoma and Hodgkin lymphoma; relapse after autologous transplants
3. Follicular lymphoma; failure of at least one prior regimen
4. CLL; failure of prior therapy which includes Fludarabine combinations or 17p- cytogenetic abnormality
3. Patients must have an HLA matched related or unrelated donor willing to donate either peripheral blood stem cells or bone marrow. Matching is based on high-resolution class I (HLA-A, -B, -C) and class II (HLA-DRB1, -DQB) typing. The goal is to transplant \> 3 x 106 CD34+ cells per kg body weight of the recipient
4. Patients must sign written informed consent.
5. Adequate birth control in fertile patients.
You may not be if
1. Bilirubin \> 3.0 mg/dl, transaminases \> 3 times upper normal limit
